ARTICLE | Clinical News
Pharmacia terminates leridistim
July 21, 2000 7:00 AM UTC
PHA discontinued its leridistim program to treat complications of chemotherapy following a review of a Phase III study in adult patients. Although the agent promoted neutrophil recovery, it produced a...